Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Circulation
|
August 5, 1997
ACE*D and cardiovascular disease
B R Winkelmann, M Verho
Pharmatherapeutica
|
January 1, 1986
Efficacy of a low fixed-dose combination of penbutolol with piretanide in the treatment of mild to moderate hypertension: a double-blind study against placebo
J Yasky, M Verho, B Rangoonwala
Current Medical Research and Opinion
|
January 1, 1988
The effects of piretanide in patients with congestive heart failure and diabetes mellitus: a double-blind comparison with furosemide
N Car, Z Skrabalo, M Verho
Pharmatherapeutica
|
January 1, 1984
The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension
M Verho, R Kirsten, C Bückert
European Journal of Clinical Pharmacology
|
January 1, 1985
Single and divided daily dose piretanide in the treatment of uncomplicated essential hypertension: a double-blind comparison with a combination of hydrochlorothiazide and amiloride
M Verho, B Rangoonwala, W Dols
Infection
|
January 1, 1986
[Clinical pharmacology of ofloxacin: a new chemotherapeutic agent belonging to the gyrase inhibitor group]
M Verho, E E Dagrosa, V Malerczyk
Current Medical Research and Opinion
|
January 1, 1987
Efficacy of a fixed-dose combination of 40 mg penbutolol with 6 mg piretanide in the treatment of mild to moderate hypertension: a double-blind study against placebo
J Yasky, M Verho, B Rangoonwala
European Journal of Clinical Pharmacology
|
January 1, 1985
Effects of a new diuretic piretanide on glucose tolerance, insulin secretion and 125I-insulin binding
K Harno, M Välimäki, M Verho
International Journal of Clinical Pharmacology Research
|
January 1, 1988
Serum selenium levels in diuretic-treated hypertensives: a double-blind trial of piretanide against hydrochlorothiazide plus amiloride
M Verho, W Bossaller, V Malerczyk
International Journal of Clinical Pharmacology Research
|
January 1, 1987
Serum trace-element levels in piretanide-treated hypertensives: a double-blind trial against hydrochlorothiazide plus amiloride
M Verho, W Bossaller, B Heinen
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Circulation
|
August 5, 1997
ACE*D and cardiovascular disease
B R Winkelmann, M Verho
Pharmatherapeutica
|
January 1, 1986
Efficacy of a low fixed-dose combination of penbutolol with piretanide in the treatment of mild to moderate hypertension: a double-blind study against placebo
J Yasky, M Verho, B Rangoonwala
Current Medical Research and Opinion
|
January 1, 1988
The effects of piretanide in patients with congestive heart failure and diabetes mellitus: a double-blind comparison with furosemide
N Car, Z Skrabalo, M Verho
Pharmatherapeutica
|
January 1, 1984
The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension
M Verho, R Kirsten, C Bückert
European Journal of Clinical Pharmacology
|
January 1, 1985
Single and divided daily dose piretanide in the treatment of uncomplicated essential hypertension: a double-blind comparison with a combination of hydrochlorothiazide and amiloride
M Verho, B Rangoonwala, W Dols
Infection
|
January 1, 1986
[Clinical pharmacology of ofloxacin: a new chemotherapeutic agent belonging to the gyrase inhibitor group]
M Verho, E E Dagrosa, V Malerczyk
Current Medical Research and Opinion
|
January 1, 1987
Efficacy of a fixed-dose combination of 40 mg penbutolol with 6 mg piretanide in the treatment of mild to moderate hypertension: a double-blind study against placebo
J Yasky, M Verho, B Rangoonwala
European Journal of Clinical Pharmacology
|
January 1, 1985
Effects of a new diuretic piretanide on glucose tolerance, insulin secretion and 125I-insulin binding
K Harno, M Välimäki, M Verho
International Journal of Clinical Pharmacology Research
|
January 1, 1988
Serum selenium levels in diuretic-treated hypertensives: a double-blind trial of piretanide against hydrochlorothiazide plus amiloride
M Verho, W Bossaller, V Malerczyk
International Journal of Clinical Pharmacology Research
|
January 1, 1987
Serum trace-element levels in piretanide-treated hypertensives: a double-blind trial against hydrochlorothiazide plus amiloride
M Verho, W Bossaller, B Heinen
Page
of 6